Caas - Version vFFR - Workstation for Novel Angio-Based Functional Lesion Assessment
From Caas Workstation
The novel angio-based functional lesion assessment: wire and adenosine free. The vFFR workflow builds a 3D reconstruction of coronary artery and assesses pressure drop, resulting in a vFFR value. Furthermore, the 3D reconstruction enables assessment of severity and percentage of stenosis.
Functional lesion information
Functional lesion information
-
Pressure drops in coronary artery
-
vFFR value
Anatomical lesion information
-
Lesion diameter
-
Percentage stenosis
-
Reference diameter
-
Obstruction length
Clinical Evidence
- vFFR is subject of two multi-center randomized clinical trials investigating the effectiveness of vFFR guided revascularization vs FFR guided revascularization in over 4000 patients:
- The FASTIII trial is led by Dr. Joost Daemen (Erasmus Medical Center, Rotterdam, The Netherlands) , investigator initiated and sponsored by the European Cardiovascular Research Institute (ECRI). All study details can be found here: https://www.ecri-trials.com/studies/fast-iii/
-
The LIPSIA STRATEGY trial is led by Prof. Holger Thiele (Herzzentrum Leipzig) and investigator initiated. More information can be found here: https://www.clinicaltrials.gov/ct2/show/NCT03497637
-
vFFR is and has been subject to multiple single and multi-center trials investigating diagnostic accuracy to predict FFR ≤ 0.8, accuracy in post-PCI setting and accuracy related to IVUS, OCT, NHPR. A full overview can be found here.
Key Product Features
- Angiographically derived pressure drop and vFFR value
- Fits seamlessly in normal cathlab workflow using just 2 contrast filled angiograms
- Vendor independent: compatible with most X-ray systems
Downloads related to this software
Customer reviews
No reviews were found for Caas - Version vFFR - Workstation for Novel Angio-Based Functional Lesion Assessment. Be the first to review!